Nevertheless, despite ERα’s protective role in BLCA initiation, evidence suggests that higher ERα expression is associated with tumor aggressiveness and unfavorable patient outcomes [5]. This evidence concerns the gene ESR1 and bladder transitional cell carcinoma.